![Sergio Duron](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sergio Duron
Directeur Général chez Enlaza Therapeutics, Inc.
Fortune : 5 M $ au 31/05/2024
Postes actifs de Sergio Duron
Sociétés | Poste | Début | Fin |
---|---|---|---|
Sova Pharmaceuticals, Inc.
![]() Sova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sova Pharmaceuticals, Inc. engages in the discovery and development of human therapeutic drugs. It provides internal clinical plan on therapies supported by the mechanism, our preclinical findings, and the development of compounds reported to act on the molecular targets of H2S that include postherpetic neuralgia, chemotherapy induced peripheral neuropathic pain (CIPN pain) and diabetic neuropathy. The company’s pre-clinical findings support large-market indications, such as osteoarthritis, rheumatoid arthritis, neuropathic pain and migraine, that we would seek to develop with a strategic partner. The company was founded by Gary W. Pace and Solomon Snyder in 2010 and is headquartered in La Jolla, CA. | Corporate Officer/Principal | - | - |
Enlaza Therapeutics, Inc.
![]() Enlaza Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enlaza Therapeutics, Inc. is a company that develops novel classes of protein therapeutics using their proprietary war-lock™ platform. The company is based in La Jolla, CA. The company's platform utilizes synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza Therapeutics is pioneering the field of covalent biologics and is building a pipeline of first-in-class covalent biologics. The CEO of the company is Sergio G. Duron. | Directeur/Membre du Conseil | - | - |
Directeur Général | - | - | |
Avalon Ventures Management LLC
![]() Avalon Ventures Management LLC Investment ManagersFinance Avalon Ventures Management LLC (Avalon Ventures Management) is a venture capital firm founded in 1983 by Kevin J. Kinsella. The firm is headquartered in La Jolla, California. | Private Equity Investor | 01/01/2021 | - |
Nerio Therapeutics, Inc.
![]() Nerio Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nerio Therapeutics, Inc. provides biotechnology services. The company is headquartered in La Jolla, CA. | Directeur Technique/Scientifique/R&D | - | - |
Fondateur | - | - |
Historique de carrière de Sergio Duron
Anciens postes connus de Sergio Duron
Sociétés | Poste | Début | Fin |
---|---|---|---|
Anexigen, Inc.
![]() Anexigen, Inc. BiotechnologyHealth Technology Anexigen, Inc. is a biotechnology company developing novel methods and compositions to combat existing and burgeoning antimicrobial threats. The company was founded by Sanford Madigan and Sergio Duron and is headquartered in La Jolla, CA. | Fondateur | - | - |
The Scripps Research Institute
![]() The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Corporate Officer/Principal | - | - |
Zacharon Pharmaceuticals, Inc.
![]() Zacharon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Zacharon Pharmaceuticals, Inc. developed small molecular drugs. The company was founded by Jeffrey D. Esko, Charles A. Glass and Brett E. Crawford in 2004 and was headquartered in Novato, CA. | Directeur/Membre du Conseil | 18/10/2010 | - |
Directeur Technique/Scientifique/R&D | 01/02/2010 | - | |
Kalypsys, Inc.
![]() Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Kalypsys, Inc. discovered and developed novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases. The firm advanced its proprietary lead program, a novel, non-corticosteroid small molecule formulated for intranasal delivery, into clinical proof of concept studies. The company was founded by Pratik Shah, Jeremy S. Caldwell, Randall W. King, Kevin D. Lustig, Peter G. Schultz and Robert Downs in 2001 and was headquartered in Solana Beach, CA. | Corporate Officer/Principal | 01/02/2010 | - |
Afraxis, Inc.
![]() Afraxis, Inc. BiotechnologyHealth Technology Afraxis, Inc. operates as a contract research organization (CRO), specializes in preclinical efficacy evaluations (in vivo and in vitro), neurotoxicity evaluations, and structure-efficacy relationship (SER)-driven medicinal chemistry. It develops Afraxis ESP, an enhanced spine analysis platform that quantifies the morphology and maturity of synaptic dendritic spines, which are fundamental to information processing by neural synapses in the brain. The company was founded by Jay B. Lichter, Carmine Stengone, Susumu Tonegawa and Ben Vollrath in 2007 and is headquartered in San Diego, CA. | Directeur Technique/Scientifique/R&D | 08/09/2009 | - |
Formation de Sergio Duron
University of Illinois | Doctorate Degree |
The University of Texas at Austin | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 12 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 3 |
Director/Board Member | 2 |
Sectorielle
Health Technology | 6 |
Consumer Services | 4 |
Commercial Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 8 |
---|---|
Afraxis, Inc.
![]() Afraxis, Inc. BiotechnologyHealth Technology Afraxis, Inc. operates as a contract research organization (CRO), specializes in preclinical efficacy evaluations (in vivo and in vitro), neurotoxicity evaluations, and structure-efficacy relationship (SER)-driven medicinal chemistry. It develops Afraxis ESP, an enhanced spine analysis platform that quantifies the morphology and maturity of synaptic dendritic spines, which are fundamental to information processing by neural synapses in the brain. The company was founded by Jay B. Lichter, Carmine Stengone, Susumu Tonegawa and Ben Vollrath in 2007 and is headquartered in San Diego, CA. | Health Technology |
Zacharon Pharmaceuticals, Inc.
![]() Zacharon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Zacharon Pharmaceuticals, Inc. developed small molecular drugs. The company was founded by Jeffrey D. Esko, Charles A. Glass and Brett E. Crawford in 2004 and was headquartered in Novato, CA. | Health Technology |
Kalypsys, Inc.
![]() Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Kalypsys, Inc. discovered and developed novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases. The firm advanced its proprietary lead program, a novel, non-corticosteroid small molecule formulated for intranasal delivery, into clinical proof of concept studies. The company was founded by Pratik Shah, Jeremy S. Caldwell, Randall W. King, Kevin D. Lustig, Peter G. Schultz and Robert Downs in 2001 and was headquartered in Solana Beach, CA. | Health Technology |
Sova Pharmaceuticals, Inc.
![]() Sova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sova Pharmaceuticals, Inc. engages in the discovery and development of human therapeutic drugs. It provides internal clinical plan on therapies supported by the mechanism, our preclinical findings, and the development of compounds reported to act on the molecular targets of H2S that include postherpetic neuralgia, chemotherapy induced peripheral neuropathic pain (CIPN pain) and diabetic neuropathy. The company’s pre-clinical findings support large-market indications, such as osteoarthritis, rheumatoid arthritis, neuropathic pain and migraine, that we would seek to develop with a strategic partner. The company was founded by Gary W. Pace and Solomon Snyder in 2010 and is headquartered in La Jolla, CA. | Health Technology |
Anexigen, Inc.
![]() Anexigen, Inc. BiotechnologyHealth Technology Anexigen, Inc. is a biotechnology company developing novel methods and compositions to combat existing and burgeoning antimicrobial threats. The company was founded by Sanford Madigan and Sergio Duron and is headquartered in La Jolla, CA. | Health Technology |
Enlaza Therapeutics, Inc.
![]() Enlaza Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enlaza Therapeutics, Inc. is a company that develops novel classes of protein therapeutics using their proprietary war-lock™ platform. The company is based in La Jolla, CA. The company's platform utilizes synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza Therapeutics is pioneering the field of covalent biologics and is building a pipeline of first-in-class covalent biologics. The CEO of the company is Sergio G. Duron. | Commercial Services |
Avalon Ventures Management LLC
![]() Avalon Ventures Management LLC Investment ManagersFinance Avalon Ventures Management LLC (Avalon Ventures Management) is a venture capital firm founded in 1983 by Kevin J. Kinsella. The firm is headquartered in La Jolla, California. | Finance |
Nerio Therapeutics, Inc.
![]() Nerio Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nerio Therapeutics, Inc. provides biotechnology services. The company is headquartered in La Jolla, CA. | Commercial Services |
- Bourse
- Insiders
- Sergio Duron
- Expérience